Close

INVO Bioscience Management Letter to Shareholders Jan 7, 2021 09:00AM
INVO Bioscience Reports Third Quarter 2020 Financial Results Nov 16, 2020 04:20PM
INVO Bioscience Announces Pricing of Follow-on Public Offering and Listing on the NASDAQ Capital Market Nov 12, 2020 09:40PM